ATE514780T1 - Zusammensetzungen für die therapie und diagnose von brustkrebs und verwendung davon - Google Patents

Zusammensetzungen für die therapie und diagnose von brustkrebs und verwendung davon

Info

Publication number
ATE514780T1
ATE514780T1 AT00919352T AT00919352T ATE514780T1 AT E514780 T1 ATE514780 T1 AT E514780T1 AT 00919352 T AT00919352 T AT 00919352T AT 00919352 T AT00919352 T AT 00919352T AT E514780 T1 ATE514780 T1 AT E514780T1
Authority
AT
Austria
Prior art keywords
breast cancer
diagnosis
polypeptides
compositions
therapy
Prior art date
Application number
AT00919352T
Other languages
English (en)
Inventor
Jiang Yuqiu
Davin Dillon
Jennifer Mitcham
Jiangchun Xu
Susan Harlocker
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/339,338 external-priority patent/US6573368B2/en
Priority claimed from US09/389,681 external-priority patent/US6518237B1/en
Priority claimed from US09/433,826 external-priority patent/US6579973B1/en
Application filed by Corixa Corp filed Critical Corixa Corp
Application granted granted Critical
Publication of ATE514780T1 publication Critical patent/ATE514780T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/11—T-cells, e.g. tumour infiltrating lymphocytes [TIL] or regulatory T [Treg] cells; Lymphokine-activated killer [LAK] cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/41—Vertebrate antigens
    • A61K40/42—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT00919352T 1999-04-02 2000-02-15 Zusammensetzungen für die therapie und diagnose von brustkrebs und verwendung davon ATE514780T1 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US09/285,480 US6590076B1 (en) 1999-04-02 1999-04-02 Compositions for the treatment and diagnosis of breast cancer and methods for their use
US09/339,338 US6573368B2 (en) 1998-12-28 1999-06-23 Compositions for the treatment and diagnosis of breast cancer and methods for their use
US09/389,681 US6518237B1 (en) 1998-12-28 1999-09-02 Compositions for treatment and diagnosis of breast cancer and methods for their use
US09/433,826 US6579973B1 (en) 1998-12-28 1999-11-03 Compositions for the treatment and diagnosis of breast cancer and methods for their use
PCT/US2000/005308 WO2000060076A2 (en) 1999-04-02 2000-02-15 Compositions for the treatment and diagnosis of breast cancer and methods for their use

Publications (1)

Publication Number Publication Date
ATE514780T1 true ATE514780T1 (de) 2011-07-15

Family

ID=27804894

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00919352T ATE514780T1 (de) 1999-04-02 2000-02-15 Zusammensetzungen für die therapie und diagnose von brustkrebs und verwendung davon

Country Status (5)

Country Link
US (2) US6590076B1 (de)
JP (2) JP4806124B2 (de)
AT (1) ATE514780T1 (de)
ES (1) ES2368899T3 (de)
ZA (1) ZA200108065B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU647741B2 (en) * 1989-12-01 1994-03-31 Regents Of The University Of California, The Methods and compositions for chromosome-specific staining
US20040033230A1 (en) * 1997-12-24 2004-02-19 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US7414112B2 (en) * 1998-10-08 2008-08-19 Genentech, Inc. Antibodies to PRO1550 polypeptides
US6969518B2 (en) * 1998-12-28 2005-11-29 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US7598226B2 (en) * 1998-12-28 2009-10-06 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6774226B1 (en) 1999-11-30 2004-08-10 Ludwig Institute For Cancer Research Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof
AU1807401A (en) * 1999-11-30 2001-06-12 Corixa Corporation Compositions and methods for therapy and diagnosis of breast cancer
US20040072185A1 (en) * 2000-09-15 2004-04-15 Patrizia Paterlini-Brechot Cellular genes involved in oncogenesis, products of said genes and their diagnostic and therapeutic uses
US7560242B2 (en) * 2003-11-13 2009-07-14 The Burnham Institute Metadherin polypeptides, encoding nucleic acids and methods of use
US9517240B2 (en) 2006-09-26 2016-12-13 The Regents Of The University Of California Methods and compositions for cancer prevention and treatment
WO2008039482A2 (en) * 2006-09-26 2008-04-03 The Regents Of The University Of California Methods and compositions for cancer prevention and treatment
US10294454B2 (en) 2016-08-24 2019-05-21 General Electric Company Methods and kits for cell activation

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2613988A (en) 1988-01-04 1989-08-01 E.I. Du Pont De Nemours And Company Multiple stage affinity process for isolation of specific cells from a cell mixture
US5215926A (en) 1988-06-03 1993-06-01 Cellpro, Inc. Procedure for designing efficient affinity cell separation processes
WO1991016116A1 (en) 1990-04-23 1991-10-31 Cellpro Incorporated Immunoselection device and method
EP0553288B1 (de) 1990-10-18 1997-06-18 Cellpro Incorporated Vorrichtung und verfahren zur trennung von partikeln mittels eines biegsamen gefässes
US5240856A (en) 1991-10-23 1993-08-31 Cellpro Incorporated Apparatus for cell separation
ATE270712T1 (de) 1995-03-17 2004-07-15 Wayne John Cancer Inst Nachweis von melanomenmetastasen unter verwendung eines mehrfachmarker-tests
US5986170A (en) 1995-11-13 1999-11-16 Corixa Corporation Murine model for human carcinoma
US5891857A (en) 1996-02-20 1999-04-06 Vanderbilt University Characterized BRCA1 and BRCA2 proteins and screening and therapeutic methods based on characterized BRCA1 and BRCA2 proteins
CA2269634C (en) * 1996-10-31 2010-08-17 Abbott Laboratories Reagents and methods useful for detecting diseases of the breast
JP2001527524A (ja) 1996-11-12 2001-12-25 インサイト・ファーマスーティカルズ・インコーポレイテッド ヒト乳房腫瘍特異性タンパク質
CA2280229A1 (en) 1997-02-03 1998-08-06 Human Genome Sciences, Inc. Breast cancer specific gene 1
WO1999009155A1 (en) 1997-08-19 1999-02-25 Human Genome Sciences, Inc. 70 human secreted proteins
CA2291260A1 (en) 1997-06-06 1998-12-10 Human Genome Sciences, Inc. 207 human secreted proteins
CA2293661A1 (en) * 1997-06-20 1998-12-30 Abbott Laboratories Reagents and methods useful for detecting diseases of the breast
JP3422776B2 (ja) 1998-08-04 2003-06-30 ダイアデクスアス・インコーポレーテッド 乳癌を診断、監視、病期決定、造影及び治療する新規な方法
US6579973B1 (en) 1998-12-28 2003-06-17 Corixa Corporation Compositions for the treatment and diagnosis of breast cancer and methods for their use
JP2002540761A (ja) * 1999-01-21 2002-12-03 アボット・ラボラトリーズ 乳房の疾患を検出するために有用な試薬と方法
JP2003518364A (ja) 1999-05-28 2003-06-10 ルードヴィッヒ インスティテュート フォー キャンサー リサーチ 乳癌、胃癌および前立腺癌関連抗原ならびにそれらの使用
JP2003526342A (ja) 1999-11-23 2003-09-09 ディアデクサス インコーポレーテッド 乳癌の診断、モニタニング、ステージング、イメージングおよび処置の新規方法
JP5640237B2 (ja) 1999-11-30 2014-12-17 ルードヴィッヒ インスティテュート フォー キャンサー リサーチ リミテッド 癌関連抗原をコードする単離された核酸分子、その抗原そのものおよびその使用

Also Published As

Publication number Publication date
JP2002540789A (ja) 2002-12-03
US20030229020A1 (en) 2003-12-11
ZA200108065B (en) 2003-03-06
US6590076B1 (en) 2003-07-08
ES2368899T3 (es) 2011-11-23
JP2010239970A (ja) 2010-10-28
JP4806124B2 (ja) 2011-11-02

Similar Documents

Publication Publication Date Title
ATE345387T1 (de) Verbindungen und verfahren für therapie und diagnose von lungenkrebs
NZ330887A (en) Monoclonals and polyclonals antibodies for the diagnosis of breast cancer
DE60039353D1 (de) Verbindungen und verfahren für therapie und diagnose von lungenkrebs
BR0112542A (pt) Composições e métodos papa a terapia e a diagnose de câncer ovariano
WO1999033869A3 (en) Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
HUP0203035A2 (hu) Prosztatarák terápiájára és diagnózisára alkalmas vegyületek és eljárások
HUP0103758A2 (hu) Neurotróf faktorok
HUP0301740A2 (hu) Emlőrák kezelésére és diagnosztizálására szolgáló készítmények és eljárások
NZ512247A (en) Compositions and methods for therapy and diagnosis of ovarian cancer
HUT77491A (hu) TIE-2 ligandumok, eljárás előállításukra és felhasználásuk
HUP9802212A2 (hu) Humán terápiában alkalmazható rekombináns anti-CD4-ellenanyagok
ATE251175T1 (de) Isoliertes nukleinsäuremolekül, das für den tumorabstossungs-antigenvorläufer dage kodiert und seine verwendung
TR200103560T2 (tr) Göğüs kanserinin teşhis ve tedavisi için bileşimler ve bunların kullanımı
NO994932L (no) Blandinger og fremgangsmåter for behandling og diagnose av brystkreft
WO1997008318A3 (en) Compounds and methods for treatment and diagnosis of prostate cancer
ZA963907B (en) Insolated nucleic acid molecules peptides which form complexes with mhc molecule hla-a2 and uses thereof
ATE278408T1 (de) Arsenic hexaoxide (as406) für die verwendung in krebs-therapie und pharmazeutische zubereitungen
BR0009608A (pt) Compostos para imunoterapia e diagnóstico de câncer de mama e métodos para sua utilização
IL151448A0 (en) Proteins
MXPA01010186A (es) Composiciones y metodos para el tratamiento y diagnostico de cancer de mama.
ATE306668T1 (de) Diagnose von brustkrebs unter verwendung von bcmp-7 als marker
DE69942637D1 (de) Zusammensetzungen und verfahren für die therapie und diagnose von ovariumkrebs
WO1999037775A3 (en) Compositions and methods for detecting and treating breast cancer
WO1999054466A3 (en) Colon cancer-associated antigens and their diagnostic and therapeutic uses
ATE291620T1 (de) Mammakarzinom-assoziiertes gen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties